ZA9811817B - Thermodynamically stable form of (R)-3-(((4-fluorophenyl) sulphonyl) amino)-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (Ramatroban). - Google Patents

Thermodynamically stable form of (R)-3-(((4-fluorophenyl) sulphonyl) amino)-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (Ramatroban).

Info

Publication number
ZA9811817B
ZA9811817B ZA9811817A ZA9811817A ZA9811817B ZA 9811817 B ZA9811817 B ZA 9811817B ZA 9811817 A ZA9811817 A ZA 9811817A ZA 9811817 A ZA9811817 A ZA 9811817A ZA 9811817 B ZA9811817 B ZA 9811817B
Authority
ZA
South Africa
Prior art keywords
ramatroban
sulphonyl
carbazole
fluorophenyl
tetrahydro
Prior art date
Application number
ZA9811817A
Other languages
English (en)
Inventor
Alfons Grunenberg
Karl-Heinz Wahl
Klaus-Peter Voges
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of ZA9811817B publication Critical patent/ZA9811817B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA9811817A 1997-12-24 1998-12-23 Thermodynamically stable form of (R)-3-(((4-fluorophenyl) sulphonyl) amino)-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (Ramatroban). ZA9811817B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)

Publications (1)

Publication Number Publication Date
ZA9811817B true ZA9811817B (en) 1999-06-29

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811817A ZA9811817B (en) 1997-12-24 1998-12-23 Thermodynamically stable form of (R)-3-(((4-fluorophenyl) sulphonyl) amino)-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (Ramatroban).

Country Status (37)

Country Link
US (1) US6362214B1 (id)
EP (1) EP1051398B1 (id)
JP (2) JP3817668B2 (id)
KR (1) KR100586350B1 (id)
CN (1) CN1140510C (id)
AR (1) AR013803A1 (id)
AT (1) ATE263152T1 (id)
AU (1) AU744242B2 (id)
BG (1) BG65024B1 (id)
BR (1) BR9814496A (id)
CA (1) CA2313230A1 (id)
CO (1) CO4970800A1 (id)
DE (2) DE19757983A1 (id)
DK (1) DK1051398T3 (id)
ES (1) ES2218874T3 (id)
GT (1) GT199800198A (id)
HK (1) HK1034517A1 (id)
HN (1) HN1998000186A (id)
HU (1) HUP0004432A3 (id)
ID (1) ID25446A (id)
IL (1) IL136278A (id)
IN (1) IN192932B (id)
MY (1) MY116312A (id)
NO (1) NO316618B1 (id)
NZ (1) NZ504741A (id)
PE (1) PE20000115A1 (id)
PL (1) PL341359A1 (id)
PT (1) PT1051398E (id)
RU (1) RU2220137C2 (id)
SI (1) SI1051398T1 (id)
SK (1) SK285109B6 (id)
TR (1) TR200001936T2 (id)
TW (1) TW552258B (id)
UA (1) UA66832C2 (id)
UY (2) UY25324A1 (id)
WO (1) WO1999033803A1 (id)
ZA (1) ZA9811817B (id)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE543501T1 (de) * 2006-12-20 2012-02-15 Cardoz Ab Kombination von pemirolast und ramatroban zur verwendung bei der behandlung von entzündlichen erkrankungen
AU2007344274A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
US20180021302A1 (en) 2015-02-13 2018-01-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1015711B (zh) * 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法

Also Published As

Publication number Publication date
CN1282320A (zh) 2001-01-31
BR9814496A (pt) 2000-10-10
CO4970800A1 (es) 2000-11-07
NZ504741A (en) 2002-10-25
NO20003217D0 (no) 2000-06-21
AU744242B2 (en) 2002-02-21
HUP0004432A3 (en) 2002-10-28
IN192932B (id) 2004-06-12
HK1034517A1 (en) 2001-10-26
PL341359A1 (en) 2001-04-09
UY25575A1 (es) 1999-11-17
US6362214B1 (en) 2002-03-26
DE69822882D1 (en) 2004-05-06
JP2001527067A (ja) 2001-12-25
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
IL136278A (en) 2005-03-20
DE19757983A1 (de) 1999-07-01
HUP0004432A2 (hu) 2001-06-28
DK1051398T3 (da) 2004-07-19
WO1999033803A1 (en) 1999-07-08
JP3817668B2 (ja) 2006-09-06
NO20003217L (no) 2000-06-21
JP2006151977A (ja) 2006-06-15
MY116312A (en) 2003-12-31
CA2313230A1 (en) 1999-07-08
HN1998000186A (es) 1999-11-03
NO316618B1 (no) 2004-03-08
PE20000115A1 (es) 2000-03-26
EP1051398B1 (en) 2004-03-31
SI1051398T1 (en) 2004-08-31
GT199800198A (es) 1998-12-15
BG104554A (en) 2001-05-31
RU2220137C2 (ru) 2003-12-27
ID25446A (id) 2000-10-05
UA66832C2 (uk) 2004-06-15
AR013803A1 (es) 2001-01-10
IL136278A0 (en) 2001-05-20
CN1140510C (zh) 2004-03-03
AU1687499A (en) 1999-07-19
ES2218874T3 (es) 2004-11-16
JP4411269B2 (ja) 2010-02-10
PT1051398E (pt) 2004-07-30
EP1051398A1 (en) 2000-11-15
TR200001936T2 (tr) 2001-01-22
ATE263152T1 (de) 2004-04-15
KR20010033529A (ko) 2001-04-25
SK9752000A3 (en) 2001-02-12
UY25324A1 (es) 2000-12-29
BG65024B1 (bg) 2006-12-29
DE69822882T2 (de) 2005-02-03
TW552258B (en) 2003-09-11

Similar Documents

Publication Publication Date Title
SG71077A1 (en) 8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives
ZA976326B (en) Analogs of cationic proteins.
HK1029575A1 (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives.
ZA989230B (en) Prostaglandin agonists.
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
PT946100E (pt) Composicoes herbicidas contendo n-¬(4,6-dimetoxipirimidin-2-il)aminocarbonil|-5-metilsulfonamidometil-2-alcoxicarbonilbenzenossulfonamidas
AP2000001923A0 (en) 6,9.Disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines
HK1029339A1 (en) Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it
IT1283232B1 (it) Procedimento per la sintesi di 2-buten-1, 4-diesteri
TR199802520A3 (tr) 1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
ITBO970640A0 (it) Apparecchio per l'elettroemanazione di principi attivi.
DE69823394D1 (de) Verfahren zur Herstellung von 1-(9'H-Carbazol-4'-yloxy)-3-(2''-(2'''-methoxy-phenoxy)-ethylamino)-propan-2-ol ( Carvediol)
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
ZA9811817B (en) Thermodynamically stable form of (R)-3-(((4-fluorophenyl) sulphonyl) amino)-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (Ramatroban).
AU4720397A (en) Terpenylated diketopiperazines, (drimentines)
ATE288909T1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
EG24052A (en) Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol
AU8985298A (en) Novel sulphonamide derived from substituted anilines useful as medicines
EP1146040A3 (en) Method of crystallizing 2-azabicyclo(2.2.1)hept-5-en-3-one
AUPP003297A0 (en) 4,5-diaryloxazole compounds
AU6904698A (en) Herbicidal 3,5-difluoropyridines
ZA991215B (en) Process for the preparation of 1,3-disubstituted 2-nitroguanidines.
EP1052982A4 (en) AMINOTETRALINS AS AGONISTS OF 5-HT 1D $ g (a)?
AU6958898A (en) Preparation of heterocycles using 1,3-dihalopropenes
ZA983781B (en) Process for the preparation of 1,1,1,3,3-pentachlorobutane.